C121H137F4N23O17 — CID 158571896
ethyl 1-[(2-oxo-1H-pyrazin-3-yl)methyl]-4-(2-phenylethyl)piperidine-4-carboxylate;2-fluoro-N-(2-fluorobenzoyl)-N-[[4-hydroxy-1-[(2-oxo-1H-pyrazin-3-yl)methyl]piperidin-4-yl]methyl]benzamide;2-fluoro-N-[[4-hydroxy-1-[(2-oxo-1H-pyrazin-3-yl)methyl]piperidin-4-yl]methyl]benzamide;3-[[4-[(2-fluorophenoxy)methyl]-4-hydroxypiperidin-1-yl]methyl]-1H-pyrazin-2-one;3-[[4-hydroxy-4-[(2-methyl-5-phenylpyrrol-1-yl)methyl]piperidin-1-yl]methyl]-1H-pyrazin-2-one;3-[[4-(3-phenyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]methyl]-1H-pyrazin-2-one (PubChem CID 158571896) has the molecular formula C121H137F4N23O17 and a molecular weight of 2261.56 g/mol. Its IUPAC name is ethyl 1-[(2-oxo-1H-pyrazin-3-yl)methyl]-4-(2-phenylethyl)piperidine-4-carboxylate;2-fluoro-N-(2-fluorobenzoyl)-N-[[4-hydroxy-1-[(2-oxo-1H-pyrazin-3-yl)methyl]piperidin-4-yl]methyl]benzamide;2-fluoro-N-[[4-hydroxy-1-[(2-oxo-1H-pyrazin-3-yl)methyl]piperidin-4-yl]methyl]benzamide;3-[[4-[(2-fluorophenoxy)methyl]-4-hydroxypiperidin-1-yl]methyl]-1H-pyrazin-2-one;3-[[4-hydroxy-4-[(2-methyl-5-phenylpyrrol-1-yl)methyl]piperidin-1-yl]methyl]-1H-pyrazin-2-one;3-[[4-(3-phenyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]methyl]-1H-pyrazin-2-one.
| Compound Name | ethyl 1-[(2-oxo-1H-pyrazin-3-yl)methyl]-4-(2-phenylethyl)piperidine-4-carboxylate;2-fluoro-N-(2-fluorobenzoyl)-N-[[4-hydroxy-1-[(2-oxo-1H-pyrazin-3-yl)methyl]piperidin-4-yl]methyl]benzamide;2-fluoro-N-[[4-hydroxy-1-[(2-oxo-1H-pyrazin-3-yl)methyl]piperidin-4-yl]methyl]benzamide;3-[[4-[(2-fluorophenoxy)methyl]-4-hydroxypiperidin-1-yl]methyl]-1H-pyrazin-2-one;3-[[4-hydroxy-4-[(2-methyl-5-phenylpyrrol-1-yl)methyl]piperidin-1-yl]methyl]-1H-pyrazin-2-one;3-[[4-(3-phenyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]methyl]-1H-pyrazin-2-one |
|---|---|
| PubChem CID | 158571896 |
| Molecular Formula | C121H137F4N23O17 |
| Molecular Weight | 2261.56 g/mol |
| Exact Mass | 2260.05 |
| IUPAC Name | ethyl 1-[(2-oxo-1H-pyrazin-3-yl)methyl]-4-(2-phenylethyl)piperidine-4-carboxylate;2-fluoro-N-(2-fluorobenzoyl)-N-[[4-hydroxy-1-[(2-oxo-1H-pyrazin-3-yl)methyl]piperidin-4-yl]methyl]benzamide;2-fluoro-N-[[4-hydroxy-1-[(2-oxo-1H-pyrazin-3-yl)methyl]piperidin-4-yl]methyl]benzamide;3-[[4-[(2-fluorophenoxy)methyl]-4-hydroxypiperidin-1-yl]methyl]-1H-pyrazin-2-one;3-[[4-hydroxy-4-[(2-methyl-5-phenylpyrrol-1-yl)methyl]piperidin-1-yl]methyl]-1H-pyrazin-2-one;3-[[4-(3-phenyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]methyl]-1H-pyrazin-2-one |
| SMILES | CCOC(=O)C1(CCc2ccccc2)CCN(Cc2ncc[nH]c2=O)CC1.Cc1ccc(-c2ccccc2)n1CC1(O)CCN(Cc2ncc[nH]c2=O)CC1.O=C(NCC1(O)CCN(Cc2ncc[nH]c2=O)CC1)c1ccccc1F.O=C(c1ccccc1F)N(CC1(O)CCN(Cc2ncc[nH]c2=O)CC1)C(=O)c1ccccc1F.O=c1[nH]ccnc1CN1CCC(O)(COc2ccccc2F)CC1.O=c1[nH]ccnc1CN1CCC(c2nc(-c3ccccc3)no2)CC1 |
| InChI | InChI=1S/C25H24F2N4O4.C22H26N4O2.C21H27N3O3.C18H21FN4O3.C18H19N5O2.C17H20FN3O3/c26-19-7-3-1-5-17(19)23(33)31(24(34)18-6-2-4-8-20(18)27)16-25(35)9-13-30(14-10-25)15-21-22(32)29-12-11-28-21;1-17-7-8-20(18-5-3-2-4-6-18)26(17)16-22(28)9-13-25(14-10-22)15-19-21(27)24-12-11-23-19;1-2-27-20(26)21(9-8-17-6-4-3-5-7-17)10-14-24(15-11-21)16-18-19(25)23-13-12-22-18;19-14-4-2-1-3-13(14)16(24)22-12-18(26)5-9-23(10-6-18)11-15-17(25)21-8-7-20-15;24-17-15(19-8-9-20-17)12-23-10-6-14(7-11-23)18-21-16(22-25-18)13-4-2-1-3-5-13;18-13-3-1-2-4-15(13)24-12-17(23)5-9-21(10-6-17)11-14-16(22)20-8-7-19-14/h1-8,11-12,35H,9-10,13-16H2,(H,29,32);2-8,11-12,28H,9-10,13-16H2,1H3,(H,24,27);3-7,12-13H,2,8-11,14-16H2,1H3,(H,23,25);1-4,7-8,26H,5-6,9-12H2,(H,21,25)(H,22,24);1-5,8-9,14H,6-7,10-12H2,(H,20,24);1-4,7-8,23H,5-6,9-12H2,(H,20,22) |
| InChIKey | HSEIHOYUPXUBAA-UHFFFAOYSA-N |
| XLogP | 11.66 |
| TPSA | 520.72 Ų |
| H-Bond Donors | 11 |
| H-Bond Acceptors | 32 |
| Rotatable Bonds | 32 |
| Heavy Atoms | 165 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2261.56 |
| LogP ≤ 5 | 11.66 |
| H-Bond Donors ≤ 5 | 11 |
| H-Bond Acceptors ≤ 10 | 32 |
| Structural Alerts | {'alert_name': 'pyrrole_C(8)', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|